Genicular artery embolization is a minimally invasive procedure intended to reduce selected abnormal blood flow associated with an inflamed knee lining. It does not regrow cartilage or cure osteoarthritis—and sham-controlled studies have reported mixed results.
Knee osteoarthritis affects cartilage, bone, and the joint lining. In some painful knees, synovial inflammation is associated with increased small-vessel blood flow. GAE uses angiography to identify selected genicular branches and deliver microscopic particles with the goal of reducing that hypervascularity.
GAE may be discussed for selected adults with imaging-confirmed knee osteoarthritis and persistent symptoms despite a well-delivered conservative plan. There is no single symptom or X-ray grade that proves candidacy.
Uncontrolled studies often report improvement, but sham-controlled trials help separate a procedure-specific effect from natural fluctuation, co-interventions, and placebo response. Recent sham-controlled findings have not shown a consistent overall advantage.
Medical content reviewed July 2026. Research continues to evolve. Educational information only.
Osteoarthritis involves changes in cartilage, bone, and the joint lining. In some symptomatic knees, inflammation of the synovium is associated with increased small-vessel blood flow. GAE uses a catheter and imaging guidance to deliver microscopic particles to selected genicular artery branches with the goal of reducing this abnormal hypervascularity.
GAE is a symptom-management procedure. It does not rebuild cartilage, correct joint alignment, or treat every cause of knee pain. Imaging and clinical evaluation are needed before treatment.
During a typical GAE procedure:
Individual anatomy can make the procedure more complex. Careful technique is used to limit non-target embolization, but no procedure is risk-free.
Potential advantages of GAE include a small catheter access site, outpatient treatment in many cases, and no surgical alteration of the knee joint. Some studies report improved pain and function in selected patients, while other sham-controlled research has not shown a benefit beyond the placebo response.
Important limitations:
GAE may be considered for selected adults with imaging-confirmed knee osteoarthritis and persistent pain despite appropriate conservative treatment. Patient selection typically considers symptom pattern, physical examination, arthritis severity, vascular anatomy, medications, allergies, kidney function, and treatment goals.
GAE is not appropriate for every patient. A consultation with Dr. Nathanael Sabbah includes review of your history, prior treatments, and imaging. Coordination with an orthopedic, sports medicine, rheumatology, or primary-care clinician may be recommended.
Recovery instructions are individualized. Many patients are discharged after a period of observation, but driving, activity, medication, and wound-care restrictions depend on the access site, sedation, and medical history.
Temporary access-site soreness, bruising, fatigue, or a short-term pain flare may occur. Improvement, when it occurs, is usually assessed over weeks to months rather than immediately. Some patients do not improve. Contact the treating team promptly for worsening pain, fever, drainage, color change, numbness, or other concerning symptoms.
Persistent knee pain can affect work, sleep, exercise, and daily activities. A careful diagnosis is the first step because knee pain can come from osteoarthritis, injury, inflammatory disease, referred pain, or another condition.
If conservative treatment has not provided adequate relief, a consultation can help determine whether GAE should be considered alongside other options. Call (310) 929-0026 or use the appointment form to contact SoCal Interventional.
GAE is a minimally invasive catheter procedure, not open knee surgery. It does not remove or replace the joint.
Procedure and recovery-room time vary with anatomy and medical needs. Your physician will provide an individualized estimate.
GAE does not reverse osteoarthritis and cannot guarantee that knee replacement will be avoided or delayed. It generally does not prevent later orthopedic treatment.
Potential risks include bruising or bleeding at the catheter site, temporary skin discoloration, pain flare, contrast reaction, kidney injury, infection, nerve or skin injury, radiation exposure, and rare non-target embolization. Your physician will review risks specific to you.
Evidence is evolving and mixed. A 2022 sham-controlled trial reported benefit in selected patients, while a 2024 randomized sham-controlled trial did not find a clinical effect beyond sham treatment. A 2025 systematic review concluded that short-term relief may occur in selected patients but emphasized the need for more rigorous research.
Request a consultation to discuss persistent knee osteoarthritis pain and whether genicular artery embolization or another treatment may be appropriate. Call (310) 929-0026.
Please contact our office to verify coverage.
GAE is a minimally invasive catheter procedure that reduces selected abnormal blood flow associated with inflammation in an osteoarthritic knee. It does not rebuild cartilage or cure arthritis.
Improvement, when it occurs, is generally evaluated over weeks to months. The timing and degree of response vary, and some patients do not improve.
Risks can include access-site bruising or bleeding, pain flare, temporary skin discoloration, contrast reaction, kidney injury, infection, nerve or skin injury, radiation exposure, and rare non-target embolization.
No. GAE is a symptom-management option for selected patients and does not reverse osteoarthritis. Some patients may still need orthopedic treatment or knee replacement.
Call SoCal Interventional at (310) 929-0026 or submit the appointment form. A consultation is required to determine candidacy.
We serve patients in Van Nuys, Tarzana, and Irvine and welcome consultation requests from surrounding Southern California communities, including Reseda, Santa Monica, Pasadena, Beverly Hills, Long Beach, Newport Beach, Laguna Beach, Manhattan Beach, Riverside, Santa Clarita, Calabasas, Simi Valley, Tustin, Lake Forest, Mission Viejo, and Woodland Hills. Availability and candidacy are confirmed during scheduling and clinical evaluation.